ParActin (Andrographis paniculata extract)

ParActin is a standardized extract of Andrographis paniculata containing andrographolide as its primary bioactive compound. It works by inhibiting NF-κB inflammatory pathways and activating PPAR-γ receptors to support healthy inflammatory response.

Origin & History

ParActin® is a standardized herbal extract derived from Andrographis paniculata, an annual herbaceous plant in the Acanthaceae family, sustainably harvested in India, China, and Southeastern Asia. The extract is standardized to contain 50% total andrographolides (comprising andrographolide, 14-deoxyandrographolide, and neoandrographolide) and is produced through ethanol or methanol extraction methods.

Historical & Cultural Context

Andrographis paniculata is one of the most commonly used medicinal plants in Traditional Chinese Medicine and Ayurvedic medicine systems, widely cultivated across India, China, and Southeastern Asia. The plant is known as the 'king of bitters' due to its characteristic bitter flavor profile.

Health Benefits

• May support healthy inflammatory response through NF-κB inhibition and PPAR-γ activation (preliminary research)
• May protect joint cartilage by reducing inflammatory markers like IL-1β and matrix metalloproteinases (mechanism studies only)
• May support antioxidant defense through Nrf2-Keap1-ARE pathway activation, enhancing glutathione, SOD, and catalase (preclinical evidence)
• May help maintain bone health by suppressing RANKL and inducing osteoblast mineralization (mechanism studies only)
• May support respiratory health through anti-inflammatory effects in experimental models of airway conditions (animal/in-vitro studies only)

How It Works

ParActin's andrographolide content inhibits nuclear factor kappa B (NF-κB) translocation, reducing production of inflammatory cytokines like IL-1β and TNF-α. The extract activates peroxisome proliferator-activated receptor gamma (PPAR-γ) and stimulates the Nrf2-Keap1-ARE antioxidant pathway. This dual mechanism helps modulate inflammatory cascades while enhancing cellular antioxidant defenses.

Scientific Research

While the sources reference that ParActin® is 'clinically proven' and studies have shown anti-inflammatory effects in experimental models, no specific human clinical trials, PMIDs, or meta-analyses were provided in the research dossier. Additional peer-reviewed literature searches would be necessary to obtain comprehensive clinical evidence with specific study citations.

Clinical Summary

Current evidence for ParActin is primarily based on in vitro mechanism studies and preliminary research rather than large-scale human trials. Laboratory studies demonstrate its ability to reduce inflammatory markers like IL-1β and inhibit matrix metalloproteinases that degrade joint cartilage. While animal studies show promising anti-inflammatory effects, robust human clinical trials with standardized ParActin doses are limited. Most research focuses on andrographolide content rather than the specific ParActin extract formulation.

Nutritional Profile

{"bioactive_compounds": {"andrographolide": "30-40% of extract", "neoandrographolide": "1-2% of extract", "14-deoxyandrographolide": "0.5-1% of extract"}, "macronutrients": {"protein": "Negligible", "fiber": "Negligible"}, "micronutrients": {"vitamins": "Negligible", "minerals": "Negligible"}, "bioavailability_notes": "Andrographolide is the primary active compound with moderate oral bioavailability. Absorption can be enhanced with piperine or fatty meals."}

Preparation & Dosage

The research does not provide specific clinically studied dosage ranges for human use. ParActin® is standardized to 50% total andrographolides in commercial formulations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric extract, Boswellia serrata, Quercetin, Ginger extract, Black pepper extract

Safety & Interactions

Andrographis paniculata is generally well-tolerated in healthy adults, though some users may experience mild digestive upset or allergic reactions. The herb may interact with immunosuppressive medications and could potentially enhance the effects of blood-thinning drugs. Pregnant and breastfeeding women should avoid ParActin due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use as the immune-modulating effects are not fully characterized.